Members
All members
Search
Become a member
For investors
The members of Oslo Cancer Cluster

We are a non-profit member organization comprising over 60 members commited to improving the lives of cancer patients.

Our members include academic research institutions, biotech companies, pharmaceutical companies, industry, health initiatives, support groups, financial institutions and regional development players in the field of cancer R&D.

We are actively recruiting members and are open for international members as well. Today we have members from all over Scandinavia as well as Scotland.

  
Epitarget AS
Forskningsveien 2A
0373 Oslo

CEO: Esben A. Nilssen
PHONE: +4723201200
E-MAIL: mail@epitarget.com
WEB: www.epitarget.com
FOUNDED IN: 2007
NUMBER OF EMPLOYEES: 4
PRODUCT PIPELINE: Sonosensitive drug carriers
PRODUCTS ON MARKET:
CORE EXPERTISE:
Drug formulation
Drug delivery
Liposomes
COMPANY DESCRIPTION:
Epitarget AS is a privately owned Scandinavian life science company dedicated to developing cancer therapies. In current chemotherapy the whole body is treated, not only the diseased parts. The company focuses on developing technology to deliver approved and established cancer drugs exactly where they are needed by means of ultrasound mediated drug release.
 
VALUE CHAIN BUSINESS MODEL SECTOR
  • Research
  • Preclinical development

  • Pharmaceuticals

  • Drug Discovery/development
  • Drug Delivery


Latest eventsFacebookTwitterBlogVideo
Wednesday, May 23, 2012 2:30 PM
Thursday, May 31, 2012 8:30 AM
Wednesday, June 13, 2012 4:00 PM
Sunday, June 17, 2012 1:00 PM
Oslo Cancer Cluster · Vollsveien 6, 1366 Lysaker · Fax: +47 67 12 26 58 · E-mail: mbl@radforsk.no
Utviklet av React Solutions og designet av Rim Ide & kommunikasjon